Sanofi (SNY) Goodwill & Intangibles (2009 - 2026)
Sanofi's (SNY) quarterly Goodwill & Intangibles came in at $79.4 billion in Q2 2026, up 15.54% year-over-year from $68.7 billion in Q2 2025, and down 1.83% quarter-over-quarter from $80.9 billion in Q1 2026.
Analysis
Sanofi (SNY) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Sanofi has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $79.4 billion for Q2 2026.
- In Q2 2026, Goodwill & Intangibles rose 15.54% year-over-year to $79.4 billion; the TTM figure through Jun 2026 stood at $79.4 billion (up 15.54% YoY), while the FY2025 annual figure was $78.6 billion, up 10.07% from the prior year.
- Goodwill & Intangibles came in at $79.4 billion for Q2 2026 at Sanofi, down from $80.9 billion in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $82.6 billion in Q2 2024 to a low of $67.1 billion in Q1 2025.
- Average Goodwill & Intangibles over 5 years is $76.5 billion, with a median of $79.0 billion recorded in 2025.
- Year-over-year, Goodwill & Intangibles fell 16.83% in 2025 and increased 20.5% in 2026.
- Over 5 years, Goodwill & Intangibles stood at $73.0 billion in 2022, then advanced by 8.69% to $79.3 billion in 2023, then dropped by 11.07% to $70.5 billion in 2024, then climbed by 11.49% to $78.6 billion in 2025, then grew by 0.97% to $79.4 billion in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $79.4 billion in Q2 2026, $80.9 billion in Q1 2026, and $78.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.40 Bn |
| Mar 31, 2026 | 80.88 Bn |
| Dec 31, 2025 | 78.64 Bn |
| Sep 30, 2025 | 80.51 Bn |
| Jun 30, 2025 | 68.73 Bn |
| Mar 31, 2025 | 67.12 Bn |
| Dec 31, 2024 | 70.54 Bn |
| Jun 30, 2024 | 82.63 Bn |
| Dec 31, 2023 | 79.32 Bn |
| Jun 30, 2023 | 80.40 Bn |
| Dec 31, 2022 | 72.98 Bn |
| Jun 30, 2022 | 77.40 Bn |
| Dec 31, 2021 | 79.46 Bn |
| Jun 30, 2021 | 77.61 Bn |
| Dec 31, 2020 | 74.86 Bn |
| Jun 30, 2020 | 68.59 Bn |
| Dec 31, 2019 | 67.62 Bn |
| Jun 30, 2019 | 71.37 Bn |
| Dec 31, 2018 | 75.47 Bn |
| Sep 30, 2018 | 87.23 Mn |